Back
Adaptimmune Therapeutics PLC Quote, Financials, Valuation and Earnings
Trump's Legacy-Defining Momentor Strike
But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.60
Seasonality Move:
36.97%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Adaptimmune Therapeutics PLC Price Quote
$0.60
0.00 (0%)
(Updated: December 21, 2024 at 5:13 AM ET)
Adaptimmune Therapeutics PLC Key Stats
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Day range:
$0.59 - $0.61
52-week range:
$0.47 - $2.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.85
P/B ratio:
1.93%
Volume:
3.1M
Avg. volume:
2.7M
1-year change:
37.05%
Market cap:
$154.8M
Revenue:
$60.3M
EPS:
$-0.18
How Much Does Adaptimmune Therapeutics PLC Make?
Data Unavailable
Is Adaptimmune Therapeutics PLC Growing As A Company?
Data Unavailable
Adaptimmune Therapeutics PLC Stock Price Performance
-
Did Adaptimmune Therapeutics PLC Stock Go Up Last Month?Adaptimmune Therapeutics PLC share price went down by -9.01% last month
-
Did ADAP's Share Price Rise Over The Last Year?ADAP share price rose by 37.05% over the past 1 year
What Is Adaptimmune Therapeutics PLC 52-Week High & Low?
-
What Is Adaptimmune Therapeutics PLC’s 52-Week High Share Price?Adaptimmune Therapeutics PLC has traded as high as $2.05 over the past 52 weeks
-
What Is Adaptimmune Therapeutics PLC’s 52-Week Low Share Price?Adaptimmune Therapeutics PLC has traded as low as $0.47 over the past 52 weeks
Adaptimmune Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adaptimmune Therapeutics PLC?
Data Unavailable
Is Adaptimmune Therapeutics PLC Cash Flow Positive?
Data Unavailable
Adaptimmune Therapeutics PLC Return On Invested Capital
Data Unavailable
Adaptimmune Therapeutics PLC Earnings Date & Stock Price
-
What Is Adaptimmune Therapeutics PLC's Stock Price Today?A single share of ADAP can be purchased today for 0.60
-
What Is Adaptimmune Therapeutics PLC’s Stock Symbol?Adaptimmune Therapeutics PLC trades on the nasdaq under the ticker symbol: ADAP
-
When Is Adaptimmune Therapeutics PLC’s Next Earnings Date?The next quarterly earnings date for Adaptimmune Therapeutics PLC is scheduled on March 6, 2025
-
When Is ADAP's next ex-dividend date?Adaptimmune Therapeutics PLC's next ex-dividend date is December 22, 2024
-
How To Buy Adaptimmune Therapeutics PLC Stock?You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adaptimmune Therapeutics PLC Competitors
-
Who Are Adaptimmune Therapeutics PLC's Competitors?Below is a list of companies who compete with Adaptimmune Therapeutics PLC or are related in some way:
Adaptimmune Therapeutics PLC Dividend Yield
Data Unavailable
Adaptimmune Therapeutics PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 94.54% |
| Revenue: | 458.83% | 99.63% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 3.50 |
| Upside from Last Price: | 478.7% |
Major Shareholders
Data Unavailable